Aldeyra Therapeutics, Inc. 4
4 · Aldeyra Therapeutics, Inc. · Filed Jan 12, 2016
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-01-11+100,000→ 100,000 totalExercise: $6.76Exp: 2026-01-11→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares shall vest after 12 months of continuous service with the Issuer, the balance will vest in equal monthly installments over the next 36 months of continuous service with the Issuer.